(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com:
Cardiovascular Abnormalities
If you are an adult with a saccular aneurysm (penetrating atherosclerotic ulcer) and have patent iliac or femoral arteries or can tolerate a vascular conduit that allows endovascular access to the aneurysm site, you may be eligible for this study.
The research site is in Manhasset, N.Y.
More information
Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=782.
-----
Gastroesophageal Reflux Disease (GERD)
If you are an adult whose heartburn and/or GERD symptoms are well controlled due to using medication twice daily, you may qualify for this study.
The research site is in Dallas, Texas.
More information
Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=70.
-----
Post-Menopausal Osteoporosis
If you are a menopausal woman aged 40 to 64, had your last menstrual cycle less than five years ago, and have not had a hysterectomy, you may qualify for this study.
The research site is in Cleveland, Ohio.
More information
Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=679.
-----
Anemia
This study of iron deficiency anemia is recruiting volunteers.
The research site is in DeLand, Fla.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/anemia.aspx.
-----
HPV (Human Papillomavirus) Vaccine
This 42-week study will compare an investigational HPV vaccine with the Gardisil HPV vaccine.
The research site is in Richmond, Va.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/hpv.aspx.
-----
Chronic Obstructive Pulmonary Disease (COPD)
This study is for people with chronic obstructive pulmonary disease, also called COPD.
The research site is in Willoughby, Ohio.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/copd.aspx.
-----
Copyright 2009 CenterWatch and ClinicalConnection.com. All rights reserved.
